ArticleEuropean journal of medicinal chemistry2021

A first-in-class anticancer dual HDAC2/FAK inhibitors bearing hydroxamates/benzamides capped by pyridinyl-1,2,4-triazoles.

Muhamad Mustafa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.